Secondary Polycythemia in Men Receiving Testosterone Therapy Increases Risk of Major Adverse Cardiovascular Events and Venous Thromboembolism in the First Year of Therapy. Reply

J Urol. 2022 Sep;208(3):567. doi: 10.1097/JU.0000000000002791. Epub 2022 Jun 1.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Hormone Replacement Therapy / adverse effects
  • Humans
  • Hypogonadism* / drug therapy
  • Male
  • Polycythemia* / chemically induced
  • Polycythemia* / epidemiology
  • Testosterone / adverse effects
  • Venous Thromboembolism* / chemically induced
  • Venous Thromboembolism* / epidemiology

Substances

  • Testosterone